Uncategorized

Biopharma Could Provide a Haven for Investment as Middle East Conflict Roils Global Markets

Published

3 weeks ago

on

Biotech, in particular companies that are pre-commercial with a longer-duration risk profile, could be great investments as Operation Epic Fury rolls on, according to a Truist Securities analysis.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version